This Article  • Extract  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA

JAMA. 2001;285:475-476.

Physicians in the United States, Canada, and Mexico
Physicians with current and valid licenses in the United States, Canada, or Mexico who read any 3 of the selected continuing medical education (CME) articles in this issue of JAMA, complete the CME Evaluation Form, and fax it to the number or mail it to the address at the bottom of the CME Evaluation Form are eligible for category 1 CME credit. There is no charge.

The American Medical Association (AMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor CME for physicians. The AMA designates this educational activity for up to 1 hour of category 1 CME credit per JAMA issue toward the AMA Physician's Recognition Award (PRA). Each physician should claim for credit only those hours that were actually spent in this educational activity.

Physicians in Other Countries
Physicians with current and valid licenses in the United States, Mexico, or Canada are eligible for CME credit even if they live or practice in other countries. Physicians licensed in other countries are also welcome to participate in this CME activity. However, the PRA is available only to physicians licensed in the United States, Canada, or Mexico.

Earning Credit and the CME Evaluation Form
To earn credit, read 3 of the articles listed below that are designated for CME credit carefully and complete the CME Evaluation Form. The CME Evaluation Form must be submitted within 1 month of the issue date. A certificate awarding 1 hour of category 1 CME credit will be faxed or mailed to you; it is then your responsibility to maintain a record of credit received.

One of our goals is to assess continually the educational needs of our readers so we may enhance the educational effectiveness of JAMA. To achieve this goal, we need your help. You must complete the CME Evaluation Form to receive credit.

Statement of Educational Purpose
JAMA is a general medical journal. Its mission and educational purpose is to promote the science and art of medicine and the betterment of the public health. A flexible curriculum of article topics is developed annually by THE JOURNAL's editorial board and is then supplemented throughout the year with information gained from readers, authors, reviewers, and editors. To accommodate the diversity of practice types within JAMA's readership, the Reader's Choice CME activity allows readers, as adult learners, to determine their own educational needs and to assist the editors in addressing their needs in future issues.

Readers of JAMA should be able to attain the following educational objectives: (1) select and read at least 3 articles in 1 issue to gain new medical information on topics of particular interest to them as physicians, (2) assess the articles' value to them as practicing physicians, and (3) think carefully about how this new information may influence their own practices. The educational objective for each CME article is given after the article title below.

CME Articles in This Issue of JAMA
The following articles in this issue may be read for CME credit:

-Lactam Antibiotic and -Lactamase Inhibitor Combinations386

Educational Objective: To learn about the pharmacology and clinical indications for -lactam/inhibitor combinations.

Promotion of Breastfeeding Intervention Trial (PROBIT): A Randomized Trial in the Republic of Belarus413

Educational Objective: To learn that an intervention to promote breastfeeding may reduce the risk of gastrointestinal tract infections and atopic eczema in infancy.

Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons421

Educational Objective: To learn that increased cost-sharing for prescription drugs may have adverse effects on the health of welfare recipients and older adults.

Early Statin Treatment Following Acute Myocardial Infarction and 1-Year Survival430

Educational Objective: To learn that early statin treatment of patients with myocardial infarction may reduce 1-year mortality rates.

Completeness of Safety Reporting in Randomized Trials: An Evaluation of 7 Medical Areas437

Educational Objective: To learn that safety outcomes may be underreported in randomized trials.

Safety Outcomes in Meta-analyses of Phase 2 vs Phase 3 Randomized Trials: Intracranial Hemorrhage in Trials of Bolus Thrombolytic Therapy444

Educational Objective: To learn that phase 2 and phase 3 drug trials may have different safety outcomes.

Evaluation of a Risk Assessment Questionnaire Used to Target Tuberculin Skin Testing in Children451

Educational Objective: To learn the accuracy of a screening questionnaire for identifying children who require a tuberculin skin test.

A 25-Year-Old Woman With Bipolar Disorder454

Educational Objective: To review the clinical management of bipolar disorder.

After reading 3 of these articles, complete the CME Evaluation Form.

RELATED ARTICLES

-Lactam Antibiotic and -Lactamase Inhibitor Combinations
Nelson L. S. Lee, K. Y. Yuen, and Cyrus R. Kumana
JAMA. 2001;285(4):386-388.
EXTRACT | FULL TEXT  

Promotion of Breastfeeding Intervention Trial (PROBIT): A Randomized Trial in the Republic of Belarus
Michael S. Kramer, Beverley Chalmers, Ellen D. Hodnett, Zinaida Sevkovskaya, Irina Dzikovich, Stanley Shapiro, Jean-Paul Collet, Irina Vanilovich, Irina Mezen, Thierry Ducruet, George Shishko, Vyacheslav Zubovich, Dimitri Mknuik, Elena Gluchanina, Viktor Dombrovskiy, Anatoly Ustinovitch, Tamara Kot, Natalia Bogdanovich, Lydia Ovchinikova, Elisabet Helsing, and for the PROBIT Study Group
JAMA. 2001;285(4):413-420.
ABSTRACT | FULL TEXT  

Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons
Robyn Tamblyn, Rejean Laprise, James A. Hanley, Michael Abrahamowicz, Susan Scott, Nancy Mayo, Jerry Hurley, Roland Grad, Eric Latimer, Robert Perreault, Peter McLeod, Allen Huang, Pierre Larochelle, and Louise Mallet
JAMA. 2001;285(4):421-429.
ABSTRACT | FULL TEXT  

Early Statin Treatment Following Acute Myocardial Infarction and 1-Year Survival
Ulf Stenestrand, Lars Wallentin, and for the Swedish Register of Cardiac Intensive Care
JAMA. 2001;285(4):430-436.
ABSTRACT | FULL TEXT  

Completeness of Safety Reporting in Randomized Trials: An Evaluation of 7 Medical Areas
John P. A. Ioannidis and Joseph Lau
JAMA. 2001;285(4):437-443.
ABSTRACT | FULL TEXT  

Safety Outcomes in Meta-analyses of Phase 2 vs Phase 3 Randomized Trials: Intracranial Hemorrhage in Trials of Bolus Thrombolytic Therapy
John W. Eikelboom, Shamir R. Mehta, Janice Pogue, and Salim Yusuf
JAMA. 2001;285(4):444-450.
ABSTRACT | FULL TEXT  

Evaluation of a Risk Assessment Questionnaire Used to Target Tuberculin Skin Testing in Children
Philip O. Ozuah, Theresa P. Ozuah, Ruth E. K. Stein, William Burton, and Michael Mulvihill
JAMA. 2001;285(4):451-453.
ABSTRACT | FULL TEXT  

A 25-Year-Old Woman With Bipolar Disorder
Gary S. Sachs
JAMA. 2001;285(4):454-462.
EXTRACT | FULL TEXT